Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging

Jay H. Traverse(Abbott Northwestern Hospital), Timothy D. Henry(Research Network (United States)), Lemuel A. Moye'(Research Network (United States))
American Heart Journal
October 1, 2011
Cited by 42

Abstract


Related Papers

No related papers found

Powered by citation graph analysis